Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review

Although recent advances in novel treatment approaches and therapeutics have shifted the treatment landscape of multiple myeloma, it remains an incurable plasma cell malignancy. Growing knowledge of the genome and expressed genomic information characterizing the biologic behavior of multiple myeloma...

Full description

Saved in:
Bibliographic Details
Main Authors: Taiga Nishihori, Kenneth Shain
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Genomics
Online Access:http://dx.doi.org/10.1155/2017/6934183
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554266473005056
author Taiga Nishihori
Kenneth Shain
author_facet Taiga Nishihori
Kenneth Shain
author_sort Taiga Nishihori
collection DOAJ
description Although recent advances in novel treatment approaches and therapeutics have shifted the treatment landscape of multiple myeloma, it remains an incurable plasma cell malignancy. Growing knowledge of the genome and expressed genomic information characterizing the biologic behavior of multiple myeloma continues to accumulate. However, translation and incorporation of vast molecular understanding of complex tumor biology to deliver personalized and precision treatment to cure multiple myeloma have not been successful to date. Our review focuses on current evidence and understanding of myeloma biology with characterization in the context of genomic and molecular alterations. We also discuss future clinical application of the genomic and molecular knowledge, and more translational research is needed to benefit our myeloma patients.
format Article
id doaj-art-0588eb907b81402fbe3088cd5e6cfda2
institution Kabale University
issn 2314-436X
2314-4378
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Genomics
spelling doaj-art-0588eb907b81402fbe3088cd5e6cfda22025-02-03T05:51:55ZengWileyInternational Journal of Genomics2314-436X2314-43782017-01-01201710.1155/2017/69341836934183Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical ReviewTaiga Nishihori0Kenneth Shain1Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USADepartment of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USAAlthough recent advances in novel treatment approaches and therapeutics have shifted the treatment landscape of multiple myeloma, it remains an incurable plasma cell malignancy. Growing knowledge of the genome and expressed genomic information characterizing the biologic behavior of multiple myeloma continues to accumulate. However, translation and incorporation of vast molecular understanding of complex tumor biology to deliver personalized and precision treatment to cure multiple myeloma have not been successful to date. Our review focuses on current evidence and understanding of myeloma biology with characterization in the context of genomic and molecular alterations. We also discuss future clinical application of the genomic and molecular knowledge, and more translational research is needed to benefit our myeloma patients.http://dx.doi.org/10.1155/2017/6934183
spellingShingle Taiga Nishihori
Kenneth Shain
Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
International Journal of Genomics
title Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
title_full Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
title_fullStr Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
title_full_unstemmed Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
title_short Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
title_sort insights on genomic and molecular alterations in multiple myeloma and their incorporation towards risk adapted treatment strategy concise clinical review
url http://dx.doi.org/10.1155/2017/6934183
work_keys_str_mv AT taiganishihori insightsongenomicandmolecularalterationsinmultiplemyelomaandtheirincorporationtowardsriskadaptedtreatmentstrategyconciseclinicalreview
AT kennethshain insightsongenomicandmolecularalterationsinmultiplemyelomaandtheirincorporationtowardsriskadaptedtreatmentstrategyconciseclinicalreview